Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biosynthema

Biosynthema
2001 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of drug development and discovery services. The company develops and researches on radiopharmaceuticals for diagnostic and therapeutic applications.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 4041 Forest Park Avenue
  • Saint Louis, MO 63108
  • United States

+1 (314) 000-0000

Biosynthema Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Biosynthema‘s full profile, request access.

Request full access to PitchBook

Biosynthema Executive Team (1)

Name Title Board
Seat
Contact
Info
Jack Erion Ph.D President and Chief Executive Officer